Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 36
Summary
- Conditions
- Anaplastic Astrocytoma
- Anaplastic Oligoastrocytoma
- Anaplastic Oligodendroglioma
- Astrocytoma, Grade III
- Astrocytoma, Grade IV
- Brain Cancer
- Glioblastoma Multiforme
- Glioma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: A Phase I study of neural stem cell based virotherapy in combination with standard radiation and chemotherapy for patients with newly diagnosed malignant gliomaMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03072134
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Maciej S Lesniak, MD Northwestern University
Get Well Soon